Yüklüyor......
Progress of immune checkpoint LAG-3 in immunotherapy
Immune checkpoint inhibition has been shown to successfully reactivate T cell responses directed against tumor-associated antigens, resulting in significantly prolonged overall survival in patients with various types of solid tumors. Among them, cytotoxic T-lymphocyte protein 4 (CTLA-4) and programm...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491111/ https://ncbi.nlm.nih.gov/pubmed/32963613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12070 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|